Avalo Therapeutics, Inc.
AVTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35 | -$32 | -$42 | -$84 |
| Dep. & Amort. | $0 | $0 | $0 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $3 | $0 | $8 |
| Change in WC | -$5 | -$9 | -$0 | $3 |
| Other Non-Cash | -$15 | $6 | $15 | $1 |
| Operating Cash Flow | -$49 | -$31 | -$27 | -$71 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$21 | -$15 | $33 |
| Stock Issued | $116 | $46 | $0 | $72 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $60 | $0 | $0 | $2 |
| Financing Cash Flow | $176 | $25 | -$15 | $107 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $127 | -$6 | -$41 | $36 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8 | $13 | $55 | $19 |
| End Cash | $135 | $8 | $13 | $55 |
| Free Cash Flow | -$49 | -$31 | -$27 | -$71 |